TRAC and graft versus host disease: To reduce the chances of GVHD, they also knocked out the T-cell receptor alpha constant (TRAC) using CRISPR-Cas9 and produced MSLN-directed 28ζ CAR-T cells with PD-1 and TCR disruption (MPTK-CAR-T cells).